115 related articles for article (PubMed ID: 13514330)
1. Palliative treatment of benign prostatic hypertrophy; value of glycine-alanine-glutamic acid combination.
FEINBLATT HM; GANT JC
J Maine Med Assoc; 1958 Mar; 49(3):99-101 passim. PubMed ID: 13514330
[No Abstract] [Full Text] [Related]
2. [Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
Ishigami J; Kuroda K
Hinyokika Kiyo; 1969 Jan; 15(1):68-75. PubMed ID: 4180035
[No Abstract] [Full Text] [Related]
3. [The conservative treatment of prostatic hypertrophy with Paraprost].
Aito K; Watsubo E
Hinyokika Kiyo; 1972 Jan; 18(1):41-4. PubMed ID: 4112552
[No Abstract] [Full Text] [Related]
4. [Clinical application of "PPC" to prostatic hypertrophy and others].
Sugiura H; Shimaya M
Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
[No Abstract] [Full Text] [Related]
5. [BPH pharmacotherapy (miscellaneous)].
Okada H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():367-72. PubMed ID: 12599602
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
[TBL] [Abstract][Full Text] [Related]
7. [Double blind test of PPC for prostatic hyperplasia].
Shimaya M; Sugiura H
Hinyokika Kiyo; 1970 May; 16(5):231-6. PubMed ID: 4194682
[No Abstract] [Full Text] [Related]
8. [Clinical study of a phytosterol extract of Prunus arborea and 3 amino acids: glycine, alanine and glutamic acid].
Cuervo Blanco E; Francia Bengoechea A; Fraile Gómez B
Arch Esp Urol; 1978; 31(1):97-8. PubMed ID: 697415
[TBL] [Abstract][Full Text] [Related]
9. [Amino acid therapy for hypertrophy of the prostate].
Shiga H; Kumamoto E; Imamura A
Hinyokika Kiyo; 1968 Aug; 14(8):625-32. PubMed ID: 4178205
[No Abstract] [Full Text] [Related]
10. [Physiopathologic considerations on the action of glutamic acid in experimental mercury poisoning].
Vrejoiu G; Theodorescu M; Winter D; Sauvard S; Stănescu C
Rev Roum Physiol; 1969; 6(2):153-8. PubMed ID: 5821597
[No Abstract] [Full Text] [Related]
11. Treatment of benign prostatic hypertrophy.
Stanley CM
Hosp Pract; 1980 Oct; 15(10):21. PubMed ID: 6158472
[No Abstract] [Full Text] [Related]
12. [Medicolegal aspects of non-surgical treatment of benign prostatic hypertrophy].
Fiori A
J Urol (Paris); 1993; 99(6):364-6. PubMed ID: 7516393
[No Abstract] [Full Text] [Related]
13. Economic evaluation of treatment strategies for benign prostatic hyperplasia--is medical therapy more costly in the long run?
Saigal CS; Movassaghi M; Pace J; Joyce G;
J Urol; 2007 Apr; 177(4):1463-7; discussion 1467. PubMed ID: 17382755
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of benign prostatic hypertrophy.
Schulman CC
Eur Urol; 1993; 23(2):261. PubMed ID: 7683983
[No Abstract] [Full Text] [Related]
15. [Treatment of benign prostatic hypertrophy].
Romics I
Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
[No Abstract] [Full Text] [Related]
16. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
17. [Treatments of benign prostatic hypertrophy and their cost-benefit relationship].
Rissanen P; Salo H; Helin-Salmivaara A; Tammela T
Duodecim; 2000; 116(13):1419-26. PubMed ID: 12001365
[No Abstract] [Full Text] [Related]
18. Acute benign prostatic hypertrophy treated with a new microcirculatory constrictor.
FICARRA BJ; MARSHALL W
Br J Clin Pract; 1958 Sep; 12(9):646-8. PubMed ID: 13584669
[No Abstract] [Full Text] [Related]
19. Should combination therapy be standard for benign prostatic hyperplasia?
Fitzpatrick JM
Nat Clin Pract Urol; 2005 Dec; 2(12):574-5. PubMed ID: 16474525
[No Abstract] [Full Text] [Related]
20. Optimising the medical management of benign prostatic hyperplasia.
Marberger M; Harkaway R; de la Rosette J
Eur Urol; 2004 Apr; 45(4):411-9. PubMed ID: 15041103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
